Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:483-492
Published online before print January 22, 2007, doi: 10.1161/CIRCULATIONAHA.106.643791
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
115/4/483    most recent
CIRCULATIONAHA.106.643791v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oceandy, D.
Right arrow Articles by Neyses, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oceandy, D.
Right arrow Articles by Neyses, L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Cell signalling/signal transduction

(Circulation. 2007;115:483-492.)
© 2007 American Heart Association, Inc.


Molecular Cardiology

Neuronal Nitric Oxide Synthase Signaling in the Heart Is Regulated by the Sarcolemmal Calcium Pump 4b

Delvac Oceandy, MD, PhD; Elizabeth J. Cartwright, PhD; Michael Emerson, PhD; Sukhpal Prehar, MSc; Florence M. Baudoin, MRes; Min Zi, MD; Nasser Alatwi, MSc; Luigi Venetucci, PhD; Kai Schuh, PhD; Judith C. Williams, PhD; Angel L. Armesilla, PhD; Ludwig Neyses, MD

From the Division of Cardiovascular and Endocrine Sciences, University of Manchester, Manchester, United Kingdom (D.O., E.J.C., M.E., S.P., F.M.B., M.Z., N.A., L.V., J.C.W., A.L.A., L.N.), and Institut fur Klinische Biochemie und Pathobiochemie, Wurzburg, Germany (K.S.).

Correspondence to Professor Ludwig Neyses, 1.302 Stopford Bldg, University of Manchester, Oxford Rd, Manchester M13 9PT, United Kingdom. E-mail Ludwig.Neyses{at}cmmc.nhs.uk

Received June 5, 2006; accepted November 10, 2006.

Background— Neuronal nitric oxide synthase (nNOS) has recently been shown to be a major regulator of cardiac contractility. In a cellular system, we have previously shown that nNOS is regulated by the isoform 4b of plasma membrane calcium/calmodulin-dependent ATPase (PMCA4b) through direct interaction mediated by a PDZ domain (PSD 95, Drosophilia Discs large protein and Zona occludens-1) on nNOS and a cognate ligand on PMCA4b. It remains unknown, however, whether this interaction has physiological relevance in the heart in vivo.

Methods and Results— We generated 2 strains of transgenic mice overexpressing either human PMCA4b or PMCA ct120 in the heart. PMCA ct120 is a highly active mutant form of the pump that does not interact with or modulate nNOS function. Calcium was extruded normally from PMCA4b-overexpressing cardiomyocytes, but in vivo, overexpression of PMCA4b reduced the ß-adrenergic contractile response. This attenuated response was not observed in ct120 transgenic mice. Treatment with a specific nNOS inhibitor (N{omega}-propyl-L-arginine) reduced the ß-adrenergic response in wild-type and ct120 transgenic mice to levels comparable to those of PMCA4b transgenic animals. No differences in lusitropic response were observed in either transgenic strain compared with wild-type littermates.

Conclusions— These data demonstrate the physiological relevance of the interaction between PMCA4b and nNOS and suggests its signaling role in the heart.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Ueda, C. Valdivia, A. Medeiros-Domingo, D. J. Tester, M. Vatta, G. Farrugia, M. J. Ackerman, and J. C. Makielski
Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex
PNAS, July 8, 2008; 105(27): 9355 - 9360.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-C. Chang, A. S. Barth, T. Sasano, E. Kizana, Y. Kashiwakura, Y. Zhang, D. B. Foster, and E. Marban
CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart
PNAS, March 18, 2008; 105(11): 4477 - 4482.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Oceandy, M. Zi, S. Prehar, T. Mohamed, P. Stanley, E. Cartwright, N. Alatwi, and L. Neyses
Abstract 340: Ablation of the Plasma Membrane Calcium ATPase 4 (PMCA4) Attenuates the Pressure Overload-Induced Hypertrophic Response and Protects against the Development of Left Ventricular Dysfunction
Circulation, October 31, 2007; 116(16_MeetingAbstracts): II_50 - II_50.



Home page
EndocrinologyHome page
X. Loyer, T. Damy, Z. Chvojkova, E. Robidel, F. Marotte, P. Oliviero, C. Heymes, and J.-L. Samuel
17{beta}-Estradiol Regulates Constitutive Nitric Oxide Synthase Expression Differentially in the Myocardium in Response to Pressure Overload
Endocrinology, October 1, 2007; 148(10): 4579 - 4584.
[Abstract] [Full Text] [PDF]